Literature DB >> 26668644

Long-term outcomes of rotational atherectomy in coronary bifurcation lesions.

Yuxiang Dai1, Atsutoshi Takagi2, Hakuoh Konishi2, Tetsuro Miyazaki2, Hiroshi Masuda2, Kazunori Shimada2, Katsumi Miyauchi2, Hiroyuki Daida2.   

Abstract

The aim of the present study was to determine the long-term outcomes of bifurcation lesions following a rotational atherectomy (ROTA). In this retrospective study, patients that had undergone a ROTA of the bifurcation coronary lesions in Juntendo University Hospital (Tokyo, Japan) were enrolled between January 2007 and December 2009, and received follow-up for a median duration of 48 months (range, 12-84 months). A total of 337 patients were enrolled. Each patient was treated with an average of 1.2±0.4 ROTA burrs (mean size, 2.9±0.3 mm). Baseline lesion length, reference diameter, minimal lumen diameter (MLD) and percentage of diameter stenosis (%DS) prior to the procedure were comparable between the DM and non-DM patients. Furthermore, MLD, %DS and acute gain following the procedure were similar between the two groups. At follow-up, DM patients exhibited a significantly decreased MLD (1.97±0.92 vs. 2.26±0.73 mm; P=0.0038), increased %DS (27.9±21.3 vs. 20.2±13.3%; P=0.022) and late loss (0.70±0.45 vs. 0.42±0.36 mm; P=0.0047) compared with the non-DM patients. Follow-up examinations (mean duration, 52.2±19.4 months) revealed that the DM patients experienced significantly higher rates of target lesion revascularization (TLR) [28 (15.7%) vs. 8 (5.0%); P=0.0011], target lesion (TL) restenosis [46 (25.8%) vs. 20 (12.6%); P=0.0019] and major adverse cardiac events (MACE) [36 (20.2%) vs. 19 (12.0%), P=0.039] compared with the non-DM patients. Although the usage of ROTA and drug-eluting stent evidently improved long-term outcomes in patients with bifurcation lesions, DM remained an independent risk factor for TLR, TL restenosis and MACE. Therefore, the management of DM in bifurcation lesions treated with ROTA requires increased investigation in future clinical practice.

Entities:  

Keywords:  coronary bifurcation lesion; long-term outcomes; rotational atherectomy

Year:  2015        PMID: 26668644      PMCID: PMC4665993          DOI: 10.3892/etm.2015.2817

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  40 in total

1.  Acceleration of restenosis by diabetes: pathogenetic implications.

Authors:  B E Sobel
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

2.  Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry).

Authors:  J Al Suwaidi; W Yeh; H A Cohen; K M Detre; D O Williams; D R Holmes
Journal:  Am J Cardiol       Date:  2001-05-15       Impact factor: 2.778

3.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

4.  Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".

Authors:  Alfredo R Galassi; Antonio Colombo; Maurice Buchbinder; Carmelo Grasso; Salvatore D Tomasello; Gian P Ussia; Corrado Tamburino
Journal:  Catheter Cardiovasc Interv       Date:  2007-06-01       Impact factor: 2.692

5.  [A new classification of coronary bifurcation lesions].

Authors:  Alfonso Medina; José Suárez de Lezo; Manuel Pan
Journal:  Rev Esp Cardiol       Date:  2006-02       Impact factor: 4.753

6.  Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions.

Authors:  J Al Suwaidi; P B Berger; C S Rihal; K N Garratt; M R Bell; H H Ting; J F Bresnahan; D E Grill; D R Holmes
Journal:  J Am Coll Cardiol       Date:  2000-03-15       Impact factor: 24.094

Review 7.  Progress in percutaneous management of coronary bifurcation lesions.

Authors:  V Dzavik
Journal:  Minerva Cardioangiol       Date:  2005-10       Impact factor: 1.347

8.  Short and long-term outcomes of two drug eluting stents in bifurcation lesions.

Authors:  Ji-lin Chen; Run-lin Gao; Yue-jin Yang; Shu-bin Qiao; Xue-wen Qin; Min Yao; Bo Xu; Hai-bo Liu; Yong-jian Wu; Jin-qing Yuan; Jue Chen; Yuan Wu; Jun Dai
Journal:  Chin Med J (Engl)       Date:  2007-02-05       Impact factor: 2.628

9.  Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study.

Authors:  R Kornowski; G S Mintz; K M Kent; A D Pichard; L F Satler; T A Bucher; M K Hong; J J Popma; M B Leon
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

10.  Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.

Authors:  Raisuke Iijima; Gjin Ndrepepa; Julinda Mehilli; Christina Markwardt; Olga Bruskina; Jürgen Pache; Maryam Ibrahim; Albert Schömig; Adnan Kastrati
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.